Dear Trader, I was ready to pounce on my first Sniper Report POTUS Catalyst Play today â but I missed out on my entry, so Iâll have to switch up my plan a bit. If the stock gets around my buy zone tomorrow... You better believe Iâm going to alert Sniper Report subscribers that Iâll be on LIVE to buy shares of the stock and teach them a bit about trading âlonger-termâ catalyst events. Let me tell you a bit about this stock. Itâs in the biotech / pharma industry â and if you know me, Iâve done all the research I possibly could on this name⦠And with the stock trading below $15, I genuinely believe this stock is grossly undervalued and has the potential to move 30%+. Listen, right now â itâs the Super Bowl for some biotech and pharma stocks⦠And I expect fireworks very soon, thatâs why I may pounce on this biotech / pharma stock as early as tomorrow after the opening bell. However, youâre going to miss out on it in its entirety because youâre not a subscriber to Sniper Report yet. Yesterday, I gave you first dibs on the 250 spots I opened up to gain annual access to Sniper Report for a measly $1 per week. You didnât take me up on the offer. [I just wanted to give you one last chance to take advantage of this no-brainer deal.]( [Weâre almost at capacity and all 250 spots may be filled up as soon as you click on this link.]( [If you click this link]( and see the $997 price point, Iâm sorry to tell you but that means all the spots were filled up. Kyle Dennis *Results presented are not typical and may vary from person to person. Please see our full disclaimer here: ragingbull.com/disclaimer RagingBull, LLC
62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com](
[Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.